Cough, Cold and Allergy (Hay Fever) Remedies in Ireland

PROSPECTS

Fewer innovations and increased competition from generics expected

Overall sales growth within cough, cold and allergy (hay fever) remedies is expected to slow down over the forecast period. The overall area has reached maturity with sales being limited by fewer innovations and tighter regulations.

Demand for decongestants to remain strong

There is likely to continue to be considerable demand for decongestant products over the forecast period. Coughs and colds remain the most common ailment for consumers.

Regulations for paediatric products to limit sales

Paediatric products will be one of the fastest declining areas over the coming years. Tight regulation will continue to be enforced by the Irish Health Product Regulatory Authority (HPRA) over the sale of cough cold and allergy products to younger consumers.

COMPETITIVE LANDSCAPE

Extreme weather fuels unprecedented sales

The majority of players in the area saw their sales bolstered by unprecedented weather conditions over the first half of 2018. An extended winter that lasted all of spring and a hot summer had a positive impact on sales of cough, cold and allergy (hay fever) remedies.

Intense competition between Reckitt Benckiser and McNeil Healthcare

Reckitt Benckiser was the leading player in 2018, with McNeil Healthcare following closely behind. McNeil’s Benylin remains the best-selling brand as it continues to enjoy strong brand recognition and loyalty, especially among parents.

Cetrine Allergy leads allergy care sales

Rowex is the leading allergy player in Ireland due to the popularity of its Cetrine Allery brand. The company was well placed to benefit from the hot summer and rising incidence of hay fever.

Files are delivered directly into your account within a few minutes of purchase.